Literature DB >> 36050623

A comprehensive qualitative framework for health-related quality of life in Duchenne muscular dystrophy.

Philip A Powell1, Jill Carlton2.   

Abstract

PURPOSE: Duchenne muscular dystrophy (DMD) is a rare x-linked neuromuscular condition predominantly affecting boys and men. There is a paucity of research qualitatively detailing the lived experience of health-related quality of life (HRQoL) for people with DMD. The aim of this study was to identify a comprehensive framework for better understanding HRQoL in DMD.
METHODS: Eighteen boys and men (aged 7 to ≥ 40 years) with DMD were recruited from charity Duchenne UK, a DMD support group, and 5 UK National Health Service Trusts. Semi-structured interviews were conducted using a topic guide informed by a review into HRQoL in DMD. Generic, preference-based, patient-reported outcome measures (PROs) were used as prompts. Interviews were audio recorded, transcribed verbatim and analysed using framework analysis.
RESULTS: Thirty-seven themes were coded, within seven categories. Six categories were conceptualised as components of HRQoL (autonomy, daily activities, feelings and emotions, identity, physical aspects, social relationships) and one considered an input (healthcare, support, and environment). Three additional themes were used to code feedback on the generic PROs (CHU-9D, EQ-5D, HUI). Social relationships received most coverage in the data and was noted as an omission from the PROs.
CONCLUSION: A 30-item framework for HRQoL in DMD has been developed, which was used as input into a new condition-specific HRQoL PRO and preference-based measure: the DMD-QoL. The data has value in its own right in highlighting the lived experience of HRQoL for people with DMD and as a barometer for assessing the content of HRQoL PROs for use in DMD.
© 2022. The Author(s).

Entities:  

Keywords:  Duchenne muscular dystrophy; Health-related quality of life; Patient-reported outcomes; Qualitative research; Rare diseases

Year:  2022        PMID: 36050623     DOI: 10.1007/s11136-022-03240-w

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  26 in total

1.  Siblings of young people with Duchenne muscular dystrophy--a qualitative study of impact and coping.

Authors:  Joy Read; Maria Kinali; Francesco Muntoni; Timothy Weaver; M Elena Garralda
Journal:  Eur J Paediatr Neurol       Date:  2010-08-21       Impact factor: 3.140

2.  Men with Duchenne muscular dystrophy and end of life planning.

Authors:  David Abbott; Helen Prescott; Karen Forbes; James Fraser; Anirban Majumdar
Journal:  Neuromuscul Disord       Date:  2016-09-28       Impact factor: 4.296

3.  A qualitative exploration of the priorities and experiences of children with Duchenne muscular dystrophy, their parents, and healthcare professionals around weight management.

Authors:  Meaghan Walker; Bhavnita Mistry; Reshma Amin; Laura McAdam; Daina Kalnins; Toni Lui; Amy C McPherson
Journal:  Disabil Rehabil       Date:  2021-12-10       Impact factor: 3.033

4.  Impact and predictors of quality of life in adults diagnosed with a genetic muscle disorder: a nationwide population-based study.

Authors:  Alice Theadom; Miriam Rodrigues; Annemarei Ranta; Gemma Poke; Donald Love; Kelly Jones; Braden Te Ao; Graeme Hammond-Tooke; Priya Parmar; Gina O'Grady; Richard Roxburgh
Journal:  Qual Life Res       Date:  2021-11-27       Impact factor: 4.147

5.  Becoming men: Gender, disability, and transitioning to adulthood.

Authors:  Barbara E Gibson; Bhavnita Mistry; Brett Smith; Karen K Yoshida; David Abbott; Sally Lindsay; Yani Hamdani
Journal:  Health (London)       Date:  2013-03-01

6.  Longing: the lived experience of spirituality in adolescents with Duchenne muscular dystrophy.

Authors:  Shelley-Rae Pehler; Martha Craft-Rosenberg
Journal:  J Pediatr Nurs       Date:  2009-05-26       Impact factor: 2.145

7.  Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy.

Authors:  Roxanna M Bendixen; Lauren P Morgenroth; Kristin L Clinard
Journal:  Clin Ther       Date:  2016-04-30       Impact factor: 3.393

Review 8.  Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis.

Authors:  Erik Landfeldt; Rachel Thompson; Thomas Sejersen; Hugh J McMillan; Janbernd Kirschner; Hanns Lochmüller
Journal:  Eur J Epidemiol       Date:  2020-02-27       Impact factor: 8.082

9.  Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents.

Authors:  Holly Landrum Peay; Ryan Fischer; Janice P Tzeng; Sharon E Hesterlee; Carl Morris; Amy Strong Martin; Colin Rensch; Edward Smith; Valeria Ricotti; Katherine Beaverson; Hannah Wand; Carol Mansfield
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

10.  Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review.

Authors:  Shelagh M Szabo; Ivana F Audhya; Daniel C Malone; David Feeny; Katherine L Gooch
Journal:  Qual Life Res       Date:  2019-12-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.